UP Pharma Conclave 1.0: CM Yogi Promises Safety, Stability, Speed to Global Pharma Investors sheeba farhat4 Feb 2026 8:16 PM ISTLucknow: Chief Minister Yogi Adityanath on Tuesday inaugurated the global congregation of investors and entrepreneurs 'Uttar Pradesh Pharma Conclave...
Dr Reddy's Russia Arm Slapped Rs 2.45 Cr VAT Penalty Parthika Patel29 Jan 2026 11:33 PM ISTNew Delhi: Drug major Dr. Reddy's Laboratories Limited's step-down wholly owned subsidiary, Dr. Reddy's Laboratories LLC, Russia, has received a tax...
Dr Reddy's Foils Email Spoofing Scam, Rs 2.16 Cr Recovered by Bengaluru Police Parthika Patel23 Jan 2026 4:25 PM ISTBengaluru: Bengaluru City Police have dismantled an international email spoofing racket and recovered Rs 2.16 crore that had been fraudulently...
USFDA Issues Post-Application Action Letter to Dr Reddy's Biologics Unit Farhat Nasim10 Jan 2026 10:29 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd has received a Post-Application Action Letter (PAAL) from the United States Food and Drug Administration...
Dr Reddy's Denosumab Biosimilar AVT03 Faces USFDA Setback After Plant Inspection Farhat Nasim1 Jan 2026 5:54 PM ISTNew Delhi: Drug major Dr Reddy's Laboratories Limited's wholly owned subsidiary, Dr. Reddy's Laboratories SA, Switzerland, has received a Complete...
Cybercriminals Trick Dr Reddy's Finance Team, Divert Rs 2.16 Crore Payment Parthika Patel10 Nov 2025 7:19 PM ISTBengaluru: In a major cybercrime incident, Dr Reddy's Laboratories Ltd has been duped of Rs 2.16 crore after hackers impersonated a senior executive...
Natco vs Novo Nordisk: Delhi High Court Directs Mediation in Wegovy Patent Dispute Farhat Nasim21 Aug 2025 9:26 PM ISTNew Delhi: Hyderabad-based Natco Pharma has filed a lawsuit against Danish drugmaker Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy...
Dr Reddy's Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML Susmita Roy17 Aug 2025 4:00 PM ISTNew Delhi: In a significant development, the pharmaceutical major, Dr. Reddy's Laboratories, has got the go-ahead from the Subject Expert Committee...
Dr Reddy's Gets SEC Nod for Higher Semaglutide Dose in Ongoing Phase III Study, Govt Sites Mandated Dr. Divya Colin30 May 2025 8:14 PM ISTNew Delhi: In response to the proposal presented by the Dr Reddy's Laboratories, the Subject Expert Committee (SEC) functional under the Central Drug...
Insurtech Giant Go Digit Buys Stake in Dr Reddy's for Rs 30 Crore Farhat Nasim27 Feb 2025 7:59 PM ISTWith this latest investment in Dr. Reddy's, Go Digit has expanded its footprint in the healthcare sector.
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIA Farhat Nasim24 Feb 2025 5:12 PM ISTVonoprazan-based GI drugs led new launches, generating Rs 187 crore from 404 brands.
Dr Reddy's Laboratories Gets CDSCO Panel Nod To Study Semaglutide in Type 2 Diabetes Mellitus Dr. Divya Colin20 Feb 2025 6:00 PM ISTNew Delhi: Responding to the proposal presented by Dr. Reddy's Laboratories, the Subject Expert Committee (SEC) functional under the Central Drug...
